Clinitech laboratory Limited has formally notified BSE Limited about the non-applicability of Related Party Transactions regulations for the financial year 2026. The company submitted an official undertaking on April 22, 2026, confirming its compliance status under SEBI regulations.

Regulatory Exemption Details

The company has confirmed that Related Party Transactions under Regulation 23 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 do not apply to its operations for the half year and financial year ended March 31, 2026. This exemption is based on the company's listing status and transaction volumes.

SME Portal Listing Benefits

As a company listed under BSE's Small and Medium Enterprises (SME) portal, Clinitech Laboratory Limited enjoys certain regulatory relaxations. The company does not exceed the threshold limit specified under the regulations, making it eligible for exemption from certain Related Party Transaction disclosure requirements.

Corporate Communication

The undertaking was addressed to the Assistant General Manager of the Department of Corporate Services at BSE Limited. The formal communication ensures transparency and regulatory compliance while informing the exchange about the company's current status regarding Related Party Transactions.

Management Authorization

The undertaking was digitally signed and authorized by Jagdish Umakant Nayak, Chairman and Managing Director of the company, on April 22, 2026. This formal authorization demonstrates the company's commitment to maintaining proper corporate governance and regulatory compliance standards.

Clinitech laboratory Limited has officially communicated to BSE Limited regarding its exemption from the Annual Secretarial Compliance Report requirement for the financial year ended March 31, 2026. The notification, dated April 15, 2026, was submitted to the Assistant General Manager of the Department of Corporate Services at BSE Limited.

Regulatory Exemption Details

The company's exemption is based on Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. According to this regulation, entities listed on SME exchanges are exempt from several corporate governance provisions that typically apply to mainboard-listed companies.

Scope of Corporate Governance Exemptions

Under the regulatory framework, SME-listed entities are exempted from multiple corporate governance provisions. The exemptions cover regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27, and specific clauses of regulation 46, along with paragraphs C, D, and E of Schedule V.

The company specifically highlighted that Regulation 24A, which mandates the submission of Annual Secretarial Compliance Reports, does not apply to entities listed on SME exchanges. This exemption allows SME-listed companies to operate with reduced compliance burdens while maintaining essential regulatory oversight.

Management Authorization

The undertaking was formally signed by Jagdish Umakant Nayak, Chairman and Managing Director of Clinitech Laboratory Limited. The digital signature was applied on April 15, 2026, at 13:05:55 +05'30', providing official authorization for the regulatory communication.

The communication serves as an official record with BSE Limited, ensuring transparency regarding the company's compliance status and regulatory obligations as an SME-listed entity.